Table 2.
Compounds that have no effect on the levels of FYVE-RFP
| Name | % of control FYVE-RFP spot intensity per cell |
||
|---|---|---|---|
| 2 h | 4 h | 8 h | |
| Tamoxifen | 77.66 ± 4.43 | 71.55 ± 0.73 | 85.37 ± 7.59 |
| Loperamide | 115.39 ± 5.20 | 123.62 ± 1.37 | 95.70 ± 12.84 |
| Amiodarone | 92.50 ± 5.51 | 89.23 ± 3.47 | 83.45 ± 3.64 |
| Pimozide | 94.42 ± 4.71 | 103.96 ± 9.06 | 73.64 ± 12.18 |
| Clozapine | 64.04 ± 2.94 | 74.79 ± 13.43 | 78.38 ± 1.35 |
| Cyclopamine | 108.75 ± 12.44 | 75.21 ± 1.18 | 96.38 ± 5.12 |
| Paxilline | 100.56 ± 0.58 | 52.37 ± 1.65 | 56.82 ± 4.44 |
| FPL-64176 | 99.43 ± 9.62 | 78.17 ± 1.90 | 87.62 ± 2.42 |
| Verapamil | 83.96 ± 20.67 | 70.15 ± 13.00 | 71.28 ± 11.29 |
| Propafenone | 114.69 ± 8.90 | 78.75 ± 18.93 | 62.87 ± 3.38 |
| Bay K-8644 | 110.18 ± 25.18 | 57.79 ± 3.76 | 79.70 ± 7.28 |
| Quinine | 70.35 ± 10.23 | 78.03 ± 6.33 | 60.70 ± 6.59 |
| SDZ-201106 | 65.87 ± 4.72 | 59.79 ± 2.38 | 72.40 ± 20.27 |
| TMB-8 | 89.59 ± 4.79 | 74.72 ± 13.74 | 78.64 ± 10.26 |
| Cyclosporin A | 73.62 ± 5.70 | 71.69 ± 27.87 | 55.82 ± 4.16 |
| NapSul-Ile-Trp-CHO | 89.37 ± 3.52 | 64.10 ± 11.47 | 62.34 ± 8.21 |
| CA-074-Me | 65.94 ± 12.73 | 79.82 ± 4.66 | 86.43 ± 4.15 |
| Ac-Leu-Leu-Nle-CHO | 72.86 ± 10.18 | 84.85 ± 2.83 | 88.42 ± 6.29 |
| CAPE | 86.89 ± 20.98 | 71.17 ± 18.70 | 69.14 ± 4.32 |
| H9 | 102.35 ± 12.94 | 79.63 ± 1.52 | 83.01 ± 6.62 |
| K252A | 76.86 ± 6.51 | 65.58 ± 9.36 | 70.33 ± 5.89 |
| AM 92016 | 68.06 ± 1.20 | 71.97 ± 15.67 | 66.35 ± 17.66 |
The procedure was the same as that in Table 1.